-
Je něco špatně v tomto záznamu ?
The effect of HI-6 on cholinesterases and on the cholinergic system of the rat bladder
O Soukup, M Pohanka, G Tobin, D Jun, J Fusek, K Musilek, J Marek, J Kassa, K Kuca
Jazyk angličtina Země Švédsko
Typ dokumentu práce podpořená grantem
- MeSH
- acetylcholinesterasa metabolismus MeSH
- agonisté muskarinových receptorů farmakologie MeSH
- biosenzitivní techniky MeSH
- butyrylcholinesterasa metabolismus MeSH
- cholinesterasové inhibitory farmakologie MeSH
- krysa rodu rattus MeSH
- methacholinchlorid farmakologie MeSH
- močový měchýř inervace účinky léků MeSH
- oximy MeSH
- parasympatický nervový systém účinky léků MeSH
- pilotní projekty MeSH
- potkani Sprague-Dawley MeSH
- pyridinové sloučeniny farmakologie MeSH
- zvířata MeSH
- Check Tag
- krysa rodu rattus MeSH
- zvířata MeSH
- Publikační typ
- práce podpořená grantem MeSH
CTIVES: The current standard treatment of organophosphate poisoning consists of an administration of anticholinergic drugs and cholinesterase reactivators (oximes). Oximes can react - except their reactivating effect on cholinesterases - directly with cholinoreceptors. HI-6 is an oxime that may have an inhibitory effect on the muscarinic receptors, too. METHODS: In our work, we have investigated an influence of HI-6 on the acetylcholinesterase (AChE), butyrylcholinesterase (BChE) and on the muscarinic receptors in vitro. The study was conducted using biosensor technique and on the rat bladder using in vitro test (tissue bath; methacholine as muscarinic agonist). IC50 for BChE from human serum was determined to be 1.01x10-6 M and for human erythrocytes AChE 3.31x10-6 M, respectively. CONCLUSION: We assume that the demonstrated contractile response can be attributed to the inhibition of the AChE at the lower concentration and to a predominant inhibition of muscarinic receptor at higher concentration of compound tested.
- 000
- 02179naa 2200481 a 4500
- 001
- bmc11006262
- 003
- CZ-PrNML
- 005
- 20120716110128.0
- 008
- 110401s2008 sw e eng||
- 009
- AR
- 040 __
- $a ABA008 $b cze $c ABA008 $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a sw
- 100 1_
- $a Soukup, Ondřej. $7 xx0253350
- 245 14
- $a The effect of HI-6 on cholinesterases and on the cholinergic system of the rat bladder / $c O Soukup, M Pohanka, G Tobin, D Jun, J Fusek, K Musilek, J Marek, J Kassa, K Kuca
- 314 __
- $a Department of Toxicology, Faculty of Military Health Sciences, University of Defence, Hradec Kralove, Czech Republic.
- 520 9_
- $a CTIVES: The current standard treatment of organophosphate poisoning consists of an administration of anticholinergic drugs and cholinesterase reactivators (oximes). Oximes can react - except their reactivating effect on cholinesterases - directly with cholinoreceptors. HI-6 is an oxime that may have an inhibitory effect on the muscarinic receptors, too. METHODS: In our work, we have investigated an influence of HI-6 on the acetylcholinesterase (AChE), butyrylcholinesterase (BChE) and on the muscarinic receptors in vitro. The study was conducted using biosensor technique and on the rat bladder using in vitro test (tissue bath; methacholine as muscarinic agonist). IC50 for BChE from human serum was determined to be 1.01x10-6 M and for human erythrocytes AChE 3.31x10-6 M, respectively. CONCLUSION: We assume that the demonstrated contractile response can be attributed to the inhibition of the AChE at the lower concentration and to a predominant inhibition of muscarinic receptor at higher concentration of compound tested.
- 590 __
- $a bohemika - dle Pubmed
- 650 _2
- $a acetylcholinesterasa $x metabolismus $7 D000110
- 650 _2
- $a zvířata $7 D000818
- 650 _2
- $a biosenzitivní techniky $7 D015374
- 650 _2
- $a butyrylcholinesterasa $x metabolismus $7 D002091
- 650 _2
- $a cholinesterasové inhibitory $x farmakologie $7 D002800
- 650 _2
- $a methacholinchlorid $x farmakologie $7 D016210
- 650 _2
- $a agonisté muskarinových receptorů $x farmakologie $7 D018721
- 650 _2
- $a oximy $7 D010091
- 650 _2
- $a parasympatický nervový systém $x účinky léků $7 D010275
- 650 _2
- $a pilotní projekty $7 D010865
- 650 _2
- $a pyridinové sloučeniny $x farmakologie $7 D011726
- 650 _2
- $a krysa rodu Rattus $7 D051381
- 650 _2
- $a potkani Sprague-Dawley $7 D017207
- 650 _2
- $a močový měchýř $x inervace $x účinky léků $7 D001743
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Pohanka, Miroslav $7 hka2010563580
- 700 1_
- $a Tobin, Gunnar
- 700 1_
- $a Jun, Daniel, $d 1976- $7 xx0040498
- 700 1_
- $a Fusek, Josef, $d 1945- $7 nlk20000076283
- 700 1_
- $a Musílek, Kamil, $d 1980- $7 xx0135628
- 700 1_
- $a Marek, Jan $7 xx0161533
- 700 1_
- $a Kassa, Jiří, $d 1956- $7 mzk2003181395
- 700 1_
- $a Kuča, Kamil, $d 1978- $7 xx0041831
- 773 0_
- $t Neuroendocrinology Letters $g Roč. 29, č. 5 (2008), s. 759-762 $x 0172-780X $w MED00168352
- 910 __
- $a ABA008 $b x $y 2
- 990 __
- $a 20110414101502 $b ABA008
- 991 __
- $a 20120716110043 $b ABA008
- 999 __
- $a ok $b bmc $g 833869 $s 698356
- BAS __
- $a 3
- BMC __
- $a 2008 $b 29 $c 5 $d 759-762 $i 0172-780X $m Neuro-endocrinology letters $n Neuro-endocrinol. lett. $x MED00168352
- LZP __
- $a 2011-1B09/dkjp